0.98%| Prev Close: | 0.06 |
|---|---|
| Open: | 0.06 |
| Bid: | 0.06 |
| Ask: | 0.06 |
| 1y Target Est: | 0.38 |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 0.06 - 0.06 |
|---|---|
| 52wk Range: | 0.06 - 0.21 |
| Volume: | 1,261,787 |
| Avg Vol (3m): | 1,687,880 |
| Market Cap: | 66.10M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in AUD.
Headlines
- 19 April 2013 Prima BioMed Quaterly Results And Conference Call >>at Reuters(Sat 20 Apr)
- DGAP-News: Prima BioMed veröffentlicht Kapitalflussrechnung für das dritte Quartal und kündigt Telefonkonferenz anat Reuters(Fri 19 Apr)
- Prima Biomed Quarterly Results and Conference CallMarketwired(Fri 19 Apr)
- Prima BioMed Awarded Japanese Patent for CVac(TM)Marketwired(Wed 17 Apr)
- 11 April 2013 Share Purchase Plan Offer Documents >>at Reuters(Fri 12 Apr)
- DGAP-News: Prima BioMed Ltd.: Außerordentliche Hauptversammlung findet am 16. Mai 2013 in Sydney statt - Angebotsunterlagen des Aktienerwerbsplans auf Website verfügbarat Reuters(Thu 11 Apr)
- DGAP-News: Prima BioMed Ltd.: Aktualisierung des Aktienerwerbsplansat Reuters(Tue 9 Apr)
- 09 April 2013 Share Purchase Plan Update >>at Reuters(Tue 9 Apr)
- DGAP-News: Prima BioMed Ltd.: BEABSICHTIGTER AKTIENERWERBSPLAN UND ANGEBOT ÜBER BÖRSENNOTIERTE OPTIONEN; EINBERUFUNG ZUR AUSSERORDENTLICHEN HAUPTVERSAMMLUNGat Reuters(Wed 3 Apr)
- 20 March 2013 3.8 million Euro grant to support CVac Development; Prima moving forward with pilot of CVac in additional cancer indications >>at Reuters(Wed 20 Mar)
Press Releases
- Prima BioMed to Present at the Second Annual Marcum LLP MicroCap ConferenceMarketwired(Mon 20 May)
- Prima BioMed Issues the Following Notice to Stockholders of the CompanyMarketwired(Fri 17 May)
- Russell J. Howard to Join Prima BioMed's Board of DirectorsMarketwired(Wed 8 May)